Acuña, Bernadeth .
HRN: 27-04-68 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/02/2025
CLINDAMYCIN 300MG (CAP)
05/02/2025
05/08/2025
ORAL
300mg
Q6
Acute Bacterial Infection
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes